These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1841793)

  • 1. New thoughts of pathophysiology and therapy of ischemic heart disease.
    Pepine CJ
    Cardiologia; 1991 Dec; 36(12 Suppl 1):373-7. PubMed ID: 1841793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine and its role in cardiovascular disease.
    Retter AS
    Heart Dis; 1999; 1(2):108-13. PubMed ID: 11720611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of metabolic therapy in myocardial infarct].
    Di Biase M; Biasco G; Rizzon P
    Cardiologia; 1991 Dec; 36(12 Suppl 1):389-92. PubMed ID: 1841795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of L-carnitine on ischemic heart disease: experimental results].
    Lerch R
    Praxis (Bern 1994); 1998 Jan; 87(4):97-100. PubMed ID: 9522638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of carnitine in cardiovascular disorders.
    Pepine CJ
    Clin Ther; 1991; 13(1):2-21; discussion 1. PubMed ID: 2029724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine administration in coronary artery disease and cardiomyopathy.
    Singh RB; Aslam M
    J Assoc Physicians India; 1998 Sep; 46(9):801-5. PubMed ID: 11229253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on experimental coronary insufficiency. Effect of L-carnitine on myocardial ischemia produced by sympathetic-nerve stimulation with high plasma fatty acids.
    Iimura O; Shoji T; Yoshida S; Sato R; Nohara K; Kudoh Y; Ishiyama N; Motoe M
    Adv Myocardiol; 1985; 6():437-49. PubMed ID: 3992042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiologic bases for the use of L-carnitine in cardiology].
    Krähenbühl S
    Praxis (Bern 1994); 1998 Jan; 87(4):102-7. PubMed ID: 9522639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortins in heart failure and ischemic heart disease.
    Boonprasert P; Lailerd N; Chattipakorn N
    Int J Cardiol; 2008 Jul; 127(3):307-12. PubMed ID: 18180061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy].
    Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Camporeale A; Gennari C
    Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Myocardium in hibernation"--implications for clinical medicine].
    Auer J; Berent R; Eber B
    Wien Med Wochenschr; 2000; 150(6):123-7. PubMed ID: 10893763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine and its derivatives in cardiovascular disease.
    Arsenian MA
    Prog Cardiovasc Dis; 1997; 40(3):265-86. PubMed ID: 9406679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart.
    Broderick TL; Quinney HA; Lopaschuk GD
    Cardiovasc Res; 1995 Mar; 29(3):373-8. PubMed ID: 7781011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.